Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
News-Medical.Net on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
GlobalData on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the ...
The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was announced by the FDA in August 2002 to improve and modernize pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results